Navigation Links
MRIGlobal, Evogen Announce Agreement In Development Of Diagnostic Solutions
Date:7/30/2013

KANSAS CITY, Mo., July 30, 2013 /PRNewswire-USNewswire/ -- MRIGlobal and Evogen Inc. today announced that they have agreed to a strategic collaboration to develop advanced molecular diagnostics products, targeted to support in vitro and clinical molecular diagnostics markets.

(Logo: http://photos.prnewswire.com/prnh/20130730/DC55501LOGO-a)

(Logo: http://photos.prnewswire.com/prnh/20130730/DC55501LOGO-b)

Evogen, based in Lenexa, Kansas, is a diagnostics company and developer and manufacturer of High Definition PCR (polymerase chain reaction) molecular diagnostics systems.

Under the new five-year agreement, MRIGlobal will provide product development services to Evogen, including assay development, technology transfer,  analytical and clinical studies, and commercialization support. Other terms of the agreement were not released.

Evogen was founded in 2002 as a spinout from MRIGlobal (then known as Midwest Research Institute). Evogen is also known for its air sampling and collection technology which is deployed in the U.S and abroad to collect air in critically sensitive situations.

"We envision a partnership built on an already strong foundation of our earlier work together," said Thomas M. Sack, Ph.D., MRIGlobal Interim President and Chief Executive Officer. "Evogen and MRIGlobal see opportunities to collaborate on delivering new and innovative solutions that can help physicians make earlier and more accurate diagnoses."

"We are very pleased to announce this partnership and look forward to expediting optimization of our molecular platform for use around the globe," said Hans Kastensmith, President and Chief Executive Officer of Evogen. "MRIGlobal is a strong partner for product research and development and together we will accelerate the delivery of advanced diagnostic products to help advance health care."

The non-exclusive agreement is effective immediately.

About Evogen, Inc.
Evogen meets the molecular diagnostic collection and detection needs of a diverse range of customers. The Evogen portfolio includes DNA extraction methodologies, air collection and monitoring and proprietary PCR probe technology providing reliable, sensitive and specific answers. Through analysis of the specific needs of each customer, Evogen delivers systems and solutions that provide rapid results while lessening laboratory workflow impact. Visit www.Evogen.com.

About MRIGlobal
MRIGlobal, a not-for-profit research and development organization, delivers solutions in global health, national security and defense, and energy and the environment. The organization performs scientific research, advanced engineering, integration, and program management for clients in government, industry, and academia. Established in 1944 as Midwest Research Institute, MRIGlobal is based in Kansas City, Mo., operates in nine states and Washington, D.C. MRIGlobal employs more than 500 and manages 2,600-plus workers through management and operations programs with government clients.

MRIGlobal's Diagnostics Division provides assay development for menu expansion in in vitro and molecular diagnostics, validation and clinical testing, sample access and reference material, and platform engineering and integration. MRIGlobal operates a Clinical Laboratory Improvement Amendments (CLIA)-laboratory accredited by the College of American Pathologists. MRIGlobal is ISO 9001 certified and employs current Good Manufacturing Practices and Good Laboratory Practices, and maintains Biosafety Level 3 laboratories.

For more information, visit www.mriglobal.org/diagnostics.


'/>"/>
SOURCE MRIGlobal
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. North South Holdings Inc. Announces its First Settlement and License Agreement.
2. Tisch MS Researchers Announce Breakthrough in Disease Monitoring
3. Naurex Announces Issuance Of New Patent For Novel Antidepressant GLYX-13
4. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
5. VirtualScopics Schedules Second Quarter 2013 Earnings Announcement
6. Endo to Announce Second Quarter 2013 Financial Results on August 6, 2013
7. BioDrain Announces Medical Advisory Board Comprised of Top Doctors and Healthcare Executive
8. NeuroSigma Announces FDA Approval to Commence Phase III Trial
9. Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013
10. The Galien Foundation Announces 2013 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
11. IRIDEX Announces Second Quarter 2013 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 2016 Research and Markets has ... Cell Therapy Market Outlook 2020" report to their ... , ,Recombinant technology has improved significantly in past years ... developed in coming years. Many cancer drugs have been ... therapies are also expected to be developed with its ...
(Date:5/3/2016)...  While you may be familiar with watching a film or TV show in high definition, ... 8MP in the Medical Industry.  Ampronix  is a renowned authorized reseller of the medical industry,s ... - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... , May 3, 2016  Specialty Silicone ... tool that shows how a cleanroom works. The ... discussions about science and technology. ... "As a technology company, SSF enthusiastically supports the ... help educators foster the next generation of innovators. ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... In an ... today GrassrootsHealth, a public health promotion and research organization, declared May as “National ... society, and other shifts in cultural behavior over the past several decades, Americans ...
(Date:5/4/2016)... ... May 04, 2016 , ... ProList is a set of ... . With ProList, editors can easily create lists for presentations, youtube productions, and ... bullet points. ProList is the perfect complement to presentation style videos. , ProList ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... engineer of patented products, announces the Everlasting Glove, a sports invention that aids ... Athletic and Sporting Goods Manufacturing industry is worth $9 billion," says Scott Cooper, ...
(Date:5/4/2016)... ... May 04, 2016 , ... Cirius, ... patent for its innovative Secure Messaging platform, which includes secure, private messaging, large ... patent extends Cirius’s portfolio of patents around innovative features for securing, tracking, and ...
(Date:5/4/2016)... ... May 04, 2016 , ... Somnoware Healthcare ... today announced it has secured $9 million in Series A funding led by ... investment will be used by Somnoware to further fulfill its mission to connect, ...
Breaking Medicine News(10 mins):